Ryoo BY - Search Results

1

Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial.

Kelley RK, Rimassa L, Cheng AL, Kaseb A, Qin S, Zhu AX, Chan SL, Melkadze T, Sukeepaisarnjaroen W, Breder V, Verset G, Gane E, Borbath I, Rangel JDG, Ryoo BY, Makharadze T, Merle P, Benzaghou F, Banerjee K, Hazra S, Fawcett J, Yau T. Kelley RK, et al. Among authors: ryoo by. Lancet Oncol. 2022 Aug;23(8):995-1008. doi: 10.1016/S1470-2045(22)00326-6. Epub 2022 Jul 4. Lancet Oncol. 2022. PMID: 35798016 Free article. Clinical Trial.

2

Adjuvant (cisplatin, etoposide, and 5-fluorouracil) chemotherapy after curative resection of gastric adenocarcinomas involving the esophagogastric junction.

Ryoo BY, Kang YK, Im YH, Kim YJ, Kim BS, Kim TY, Jung SH, Park JH, Baek HJ, Kim YC, Shim YM, Kim CM, Zo JI. Ryoo BY, et al. Am J Clin Oncol. 1999 Jun;22(3):253-7. doi: 10.1097/00000421-199906000-00008. Am J Clin Oncol. 1999. PMID: 10362331 Clinical Trial.

3

Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: a Korean Cancer Study Group trial.

Kim TW, Kang WK, Chang HM, Park JO, Ryoo BY, Ahn JS, Zang DY, Lee KH, Kang YK, Kim SR, Kim HK; Korean Cancer Study Group. Kim TW, et al. Among authors: ryoo by. Acta Oncol. 2005;44(3):230-5. doi: 10.1080/02841860510029590. Acta Oncol. 2005. PMID: 16076694 Clinical Trial.

4

Belotecan, new camptothecin analogue, is active in patients with small-cell lung cancer: results of a multicenter early phase II study.

Lee DH, Kim SW, Suh C, Lee JS, Lee JH, Lee SJ, Ryoo BY, Park K, Kim JS, Heo DS, Kim NK. Lee DH, et al. Among authors: ryoo by. Ann Oncol. 2008 Jan;19(1):123-7. doi: 10.1093/annonc/mdm437. Epub 2007 Sep 6. Ann Oncol. 2008. PMID: 17823384 Free article. Clinical Trial.

5

A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer.

Kim C, Lee JL, Ryu MH, Chang HM, Kim TW, Lim HY, Kang HJ, Park YS, Ryoo BY, Kang YK. Kim C, et al. Among authors: ryoo by. Invest New Drugs. 2011 Apr;29(2):366-73. doi: 10.1007/s10637-009-9363-0. Epub 2009 Dec 9. Invest New Drugs. 2011. PMID: 19997960 Clinical Trial.

6

Sorafenib for recurrent hepatocellular carcinoma after liver transplantation.

Yoon DH, Ryoo BY, Ryu MH, Lee SG, Hwang S, Suh DJ, Lee HC, Kim TW, Ahn CS, Kim KH, Moon DB, Kang YK. Yoon DH, et al. Among authors: ryoo by. Jpn J Clin Oncol. 2010 Aug;40(8):768-73. doi: 10.1093/jjco/hyq055. Epub 2010 May 21. Jpn J Clin Oncol. 2010. PMID: 20494947

7

Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function.

Kim JE, Ryoo BY, Ryu MH, Chang HM, Suh DJ, Lee HC, Lim YS, Kim KM, Kang YK. Kim JE, et al. Among authors: ryoo by. Cancer Chemother Pharmacol. 2011 Nov;68(5):1285-90. doi: 10.1007/s00280-011-1616-x. Epub 2011 Mar 29. Cancer Chemother Pharmacol. 2011. PMID: 21445543

8

Sorafenib dose escalation in the treatment of advanced hepatocellular carcinoma.

Kim JE, Ryoo BY, Ryu MH, Chang HM, Suh DJ, Lee HC, Lim YS, Kim KM, Kang YK. Kim JE, et al. Among authors: ryoo by. Oncology. 2012;82(2):119-25. doi: 10.1159/000336082. Epub 2012 Feb 17. Oncology. 2012. PMID: 22354124

9

A Phase II study of clinical outcomes of 3-week cycles of irinotecan and S-1 in patients with previously untreated metastatic colorectal cancer: influence of the UGT1A1 and CYP2A6 polymorphisms on clinical activity.

Choi YH, Kim TW, Kim KP, Lee SS, Hong YS, Ryu MH, Lee JL, Chang HM, Ryoo BY, Kim HS, Shin JG, Kang YK. Choi YH, et al. Among authors: ryoo by. Oncology. 2012;82(5):290-7. doi: 10.1159/000337989. Epub 2012 Apr 28. Oncology. 2012. PMID: 22555197 Clinical Trial.

10

Sorafenib alone versus sorafenib combined with transarterial chemoembolization for advanced-stage hepatocellular carcinoma: results of propensity score analyses.

Choi GH, Shim JH, Kim MJ, Ryu MH, Ryoo BY, Kang YK, Shin YM, Kim KM, Lim YS, Lee HC. Choi GH, et al. Among authors: ryoo by. Radiology. 2013 Nov;269(2):603-11. doi: 10.1148/radiol.13130150. Epub 2013 Jul 17. Radiology. 2013. PMID: 23864102

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

280 results

Search Page